Background Cutaneous leishmaniasis (CL) may manifest as single or multiple skin lesions, causing significant aesthetic impact and affecting the patient's quality of life (QoL). The objective of this study was to assess the impact of CL on the QoL. Methods The QoL of 20 patients with CL was assessed by the Dermatology Life Quality Index (DLQI). Results For 70% of patients CL had a moderate/large impact on their QoL, with ???Work and School??? being the most affected domain. This is the first study to use the DLQI to assess the impact of CL. Conclusion CL has a moderate to large negative effect on QoL
Lack of investments in drug development, lack of standardisation of clinical trials and the complexi...
BackgroundCutaneous leishmaniasis (CL) is a disease that often affects exposed skin areas and may he...
International audienceINTRODUCTION:Lack of investments in drug development, lack of standardisation ...
BackgroundUntil now, few studies have evaluated the effect of cutaneous leishmaniasis (CL) on patien...
BACKGROUND:Until now, few studies have evaluated the effect of cutaneous leishmaniasis (CL) on patie...
Abstract Background Post kala-azar dermal leishmaniasis (PKDL) is a dermatological disorder caused b...
Background: Cutaneous leishmaniasis (CL), is the most common form of a group of diseases known as le...
BackgroundThe impact of cutaneous leishmaniasis (CL) on the quality of life of patients has been neg...
BACKGROUND:The impact of cutaneous leishmaniasis (CL) on the quality of life of patients has been ne...
Cutaneous leishmaniasis (CL) is a chronic skin infection caused by Leishmania parasites, causing sin...
Cutaneous leishmaniasis (CL) is a chronic skin infection caused by Leishmania parasites, causing sin...
Abstract Background Cutaneous Leishmaniasis (CL) is a parasitic skin disease, linked to poverty, and...
International audienceBackgroundCutaneous leishmaniasis (CL) is a disease that often affects exposed...
Abstract Background This study was aimed to assess the impact of quality of life using WHOQOL-BREF i...
Cutaneous leishmaniasis (CL) is a chronic skin infection caused by Leishmania parasites, causing sin...
Lack of investments in drug development, lack of standardisation of clinical trials and the complexi...
BackgroundCutaneous leishmaniasis (CL) is a disease that often affects exposed skin areas and may he...
International audienceINTRODUCTION:Lack of investments in drug development, lack of standardisation ...
BackgroundUntil now, few studies have evaluated the effect of cutaneous leishmaniasis (CL) on patien...
BACKGROUND:Until now, few studies have evaluated the effect of cutaneous leishmaniasis (CL) on patie...
Abstract Background Post kala-azar dermal leishmaniasis (PKDL) is a dermatological disorder caused b...
Background: Cutaneous leishmaniasis (CL), is the most common form of a group of diseases known as le...
BackgroundThe impact of cutaneous leishmaniasis (CL) on the quality of life of patients has been neg...
BACKGROUND:The impact of cutaneous leishmaniasis (CL) on the quality of life of patients has been ne...
Cutaneous leishmaniasis (CL) is a chronic skin infection caused by Leishmania parasites, causing sin...
Cutaneous leishmaniasis (CL) is a chronic skin infection caused by Leishmania parasites, causing sin...
Abstract Background Cutaneous Leishmaniasis (CL) is a parasitic skin disease, linked to poverty, and...
International audienceBackgroundCutaneous leishmaniasis (CL) is a disease that often affects exposed...
Abstract Background This study was aimed to assess the impact of quality of life using WHOQOL-BREF i...
Cutaneous leishmaniasis (CL) is a chronic skin infection caused by Leishmania parasites, causing sin...
Lack of investments in drug development, lack of standardisation of clinical trials and the complexi...
BackgroundCutaneous leishmaniasis (CL) is a disease that often affects exposed skin areas and may he...
International audienceINTRODUCTION:Lack of investments in drug development, lack of standardisation ...